Wednesday, October 1, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

EFTR Trading Halt Lifted After Pending News Release

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Finances
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

At 8:55:00 AM ET on March 11, 2024, the trading halt on EFTR was lifted, allowing quotations to resume. This pause was necessary due to pending important news or regulatory issues, which could result in higher volatility once trading resumed. The trading halt was officially lifted at 8:55:00 AM ET, with quotation resumption times adjusted accordingly after the news was released.

LM Funding America, Inc. (LMFA) Stock Surges 30% on March 12, 2024: What Investors Need to Know

On March 12, 2024, LM Funding America, Inc. (LMFA) saw a significant increase in its stock performance. LMFA is currently trading in the middle of its 52-week range and above its 200-day simple moving average, indicating a relatively stable position in terms of its long-term performance.

The price of LMFA shares increased by $0.13 since the market last closed, representing a 30.27% rise in the stock price to $0.57. In pre-market trading, LMFA saw a further increase of $2.85 in its stock price.

This surge in LMFA’s stock performance could be attributed to positive news or developments related to the company, changes in market conditions, or increased investor interest. Investors who held LMFA shares likely saw a significant increase in the value of their investment on this day.

Stock prices are volatile and subject to fluctuations based on various factors. Investors should conduct thorough research, consider their risk tolerance, and consult with a financial advisor before making investment decisions. The strong performance of LMFA on March 12, 2024, highlights the potential for gains in the stock market and the risks associated with investing in individual stocks.

LMFA Stock Performance Review: Decline in Revenue and Net Income, Investors Await Turnaround

LMFA stock had a mixed performance on March 12, 2024, as the company reported its financial results for the past year and the third quarter. According to data from CNN Money, LMFA’s total revenue for the past year was $1.67 million, which represented an 88.64% decrease compared to the previous year. However, the total revenue for the third quarter was $3.42 million, showing a 7.06% increase compared to the previous quarter.

In terms of net income, LMFA reported a net loss of $29.24 million for the past year, which was a significant decrease of 714.39% compared to the previous year. However, the net loss for the third quarter was $4.42 million, showing a 2.91% increase compared to the previous quarter.

Earnings per share (EPS) for LMFA also saw a decline over the past year. The EPS for the past year was -$2.23, which represented a 472.22% decrease compared to the previous year. However, the EPS for the third quarter was -$0.33, showing a 5.04% increase compared to the previous quarter.

Investors will be closely monitoring LMFA’s future financial results to see if the company can turn around its performance and drive growth in the coming quarters.

Tags: LMFA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Market Today (1)

Revolutionizing CAR T Therapy A Groundbreaking Global Gene Editing Licensing Agreement

DrugRetailers Stock Exchange

Analysts Bullish on Academy Sports with Strong Buy Consensus

Vail Resorts Faces Setbacks in Q2 Financial Results

Recommended

Finances

How Consultancies Adapt to the Intersection of Financial Services, Web3, and AI

2 years ago
Illumina Stock

Can Illumina’s Bold Protein Analysis Strategy Reverse Its Market Slide?

4 weeks ago
NV5 Global Stock

NV5 Global Merger Finalized: Market Impact and Stock Outlook

1 month ago
Finance_Assets (3)

First Foundation Adjusts Dividend Payouts to Adapt to Market Conditions

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla Tilray TSLA Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Pharmaceutical Giant Faces Mounting Challenges as Analyst Turns Bearish

Gold Reaches Unprecedented Highs Amid US Political Turmoil

Leadership Purchases Signal Strong Confidence in Deutz AG

Thyssenkrupp’s Strategic Gamble: Can a Naval Powerhouse Rescue the Parent Company?

Sudden CFO Departure Sends Redcare Pharmacy Shares Tumbling

Idorsia Shares Surge on Heavy Trading Volume

Trending

Deutsche Bank Stock
Analysis

Significant Stakeholder Moves at Deutsche Bank Spark Market Interest

by Robert Sasse
October 1, 2025
0

A regulatory filing made after market close has drawn significant attention to Deutsche Bank, revealing substantial position...

Valneva Stock

Valneva Shares Surge on Breakthrough Vaccine Data

October 1, 2025
Covestro Stock

Covestro Shares Surge as ADNOC Acquisition Nears Approval

October 1, 2025
Novo Nordisk Stock

Pharmaceutical Giant Faces Mounting Challenges as Analyst Turns Bearish

October 1, 2025
Gold Stock

Gold Reaches Unprecedented Highs Amid US Political Turmoil

October 1, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Significant Stakeholder Moves at Deutsche Bank Spark Market Interest
  • Valneva Shares Surge on Breakthrough Vaccine Data
  • Covestro Shares Surge as ADNOC Acquisition Nears Approval

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com